ĐÁNH GIÁ KẾT QUẢ ĐIỀU TRỊ BỆNH LÝ MÀNG TRONG BẰNG KỸ THẬT BƠM SURFACTANT TẠI BỆNH VIỆN SẢN NHI HƯNG YÊN NĂM 2020-2021

Abstract

Objectives: Describe clinical and paraclinical characteristics of respiratory distress syndrome in
premature infants with endothelial disease and evaluate the results of treatment with Surfactant
technique at Hung Yen Obstetrics and Children's Hospital in 2020 - 2021.
Subjects-methods: Design of a cross-sectional descriptive study comparing before and after
Surfactant treatment. All premature infants with diagnosis confirmed treated with surfactant
(Curosurf). Administer curosurf 116mg/1 vial single dose for premature infants at a dose of 100-
160 mg/kg. Choose a convenient sample size for preterm infants who are eligible for the study.
Results: 98% of children breath well. Amniotic fluid in 94.9%; respiratory failure early in the first
hour (Silverman score >6). Exhausted breathing; moaning 82.4%, retraction 79.4%, SpO2 below
90% was 91.8% and 8.2% of children had hypothermia. There is grade 3 X-ray damage. Heart
rate, breathing rate, and FiO2 after 6 hours of treatment all decreased statistically significantly
(p<0.05).
Conclusions: Respiratory distress in premature infants appeared within 1 hour of birth (70.7%).
Surfactant treatment markedly reduced the need for FiO2. Lung lesions on chest X-ray improved
well. It is necessary to examine and manage pregnancy well to avoid premature delivery.